Concepedia

Judy S. Moyes

JS

Statistics

Publications

10

Citations

1K

H-Index

10

Active since

1988

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Universidade de São Paulo

Hospital Israelita Albert Einstein

Judy S. Moyes is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, life sciences, and iodine-123 metaiodobenzylguanidine scintigraphy.

Publications per year

1988–2023

10

Publications

10

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Partow Kebriaei, Harjeet Singh, M. Helen Huls et al. · Journal of Clinical Investigation · 2016 · 504 citations · Full text

, , +17

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 168 citations · Full text

, , +16

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Li Li, Vakul Mohanty, Jinzhuang Dou et al. · Science Advances · 2023 · 105 citations · Full text

, , +17

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma

L. S. Lashford, Judy S. Moyes, R.J. Ott et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1988 · 44 citations

, , +10

Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.

Judy S. Moyes, John W. Babich, Richard Carter et al. · PubMed · 1989 · 42 citations

, , +13

1–5 of 10